Paxil - Side Effects & Drug InteractionsParoxetine
ADVERSE REACTIONS Adverse Reactions Associated With Discontinuation of Treatment: Twenty percent (1,199/ 6,145) of patients treated with PAXIL in worldwide clinical trials in major depressive disorder and 16.1% (84/ 522), 11.8% (64/ 542), 9.4% (44/ 469), 10.7% (79/ 735), and 11.7% (79/ 676) of patients treated with PAXIL in worldwide trials in social anxiety disorder, OCD, panic disorder, GAD, and PTSD, respectively, discontinued treatment due to an adverse event. The most common events ( 1%) associated with discontinuation and considered to be drug related (i. e., those events associated with dropout at a rate approximately twice or greater for PAXIL compared to placebo) included the following: advertisement
Commonly Observed Adverse Events Major Depressive Disorder The most commonly observed adverse events associated with the use of paroxetine (incidence of 5% or greater and incidence for PAXIL at least twice that for placebo, derived from Table 1) were: Asthenia, sweating, nausea, decreased appetite, somnolence, dizziness, insomnia, tremor, nervousness, ejaculatory disturbance, and other male genital disorders. The most commonly observed adverse events associated with the use of paroxetine (incidence of 5% or greater and incidence for PAXIL at least twice that of placebo, derived from Table 2) were: Nausea, dry mouth, decreased appetite, constipation, dizziness, somnolence, tremor, sweating, impotence, and abnormal ejaculation. Panic Disorder The most commonly observed adverse events associated with the use of paroxetine (incidence of 5% or greater and incidence for PAXIL at least twice that for placebo, derived from Table 2) were: Asthenia, sweating, decreased appetite, libido decreased, tremor, abnormal ejaculation, female genital disorders, and impotence. Social Anxiety Disorder The most commonly observed adverse events associated with the use of paroxetine (incidence of 5% or greater and incidence for PAXIL at least twice that for placebo, derived from Table 2) were: Sweating, nausea, dry mouth, constipation, decreased appetite, somnolence, tremor, libido decreased, yawn, abnormal ejaculation, female genital disorders, and impotence. | ||
What's HOTGet our free newsletterPR Newswire |
|